Useful Definitions |
Additional Services


In Vitro Fertilization (IVF)
Treatment with In Vitro Fertilization (IVF) involves several
steps 1) the development of follicles (pockets of fluid that
contain the eggs) in the woman’s ovaries - referred to as
“ovarian stimulation” 2) the removal of eggs (oocytes)
from her ovaries - referred to as “egg or oocyte retrieval”
3) the patient’s partner, if applicable, will typically be
required to collect a semen sample on the day of
oocyte retrieval. Exceptions to this include those
patients using donor sperm, those utilizing a previously frozen semen sample or those having surgical retrieval of tissue or sperm extraction. 4) The fertilization of the eggs in the laboratory - referred to as “fertilization of oocytes” 5) transfer of embryos (fertilized eggs) into the (a) woman’s uterus - referred to as “embryo transfer. Patients are not guaranteed success at any or all of these steps. If adequate results are not achieved at any step, the cycle may be cancelled at the discretion of an RMIA physician.

Preimplantation Genetic Screening (PGS) / Preimplantation Genetic Diagnosis (PGD) 
Preimplantation Genetic Screening (PGS) or Preimplantation Genetic Diagnosis (PGD) is a process of screening early embryos during the in vitro process. The oocytes are retrieved, fertilized using ICSI, and after three days of growth, biopsied to obtain genetic material needed to screen the embryos. After this biopsy occurs, the embryos are kept in the laboratory while the material is being screened for a diagnosis. For information on disorders, screening, and/or candidacy for this procedure, please contact our office.

Egg Freezing
RMIA recently obtained IRB approval to cryopreserve unfertilized eggs. This “egg banking” will allow women undergoing cancer treatment an opportunity to preserve their fertility. It also allows women an opportunity to postpone pregnancy. This option should also be considered by patients who want to limit the number of fertilized eggs.

Low Sperm Amendment
The purpose of the Low Sperm Amendment is to allow certain patients a chance to participate in the Fertility Cost Warranty Programs (FCWP) even though the male patient has less than 500,000 motile sperm in his semen, a condition which would otherwise disqualify them from participation in the programs. This Amendment does not expand nor limit the terms and conditions of the FCWP as represented in the other FCWP documents executed herewith. Five options exist for those male patients who wish to participate in the FCWP despite having less than 500,000 motile sperm in the semen sample: 1)  Vasectomy Reversal, 2)  Frozen Sample Backup, 3)  Testicular Sperm Extraction, 4)  Use of Donor Sperm, 5)  Surgical Sperm Extraction.

Gestational Carrier
A gestational carrier is a woman who carries a fertilized embryo formed from another woman’s egg to term—completion of pregnancy—and is expected to release the infant to the genetic parents upon delivery. In the case of IVF with “Gestational Carrier”, a similar process takes place, with the difference that the patient is now the “donor” (and therefore undergoes ovarian stimulation and oocyte retrieval), whereas her gestational carrier becomes the “recipient”. The techniques used to synchronize the cycles are identical.

Known Donor / Agency Donor
A known donor is a woman who donates her eggs to known recipients. An agency donor is a donor that has been recruited by an approved donor agency. Patients interested in IVF using donor egg from a known donor or agency donor should call for further details.

Embryo Adoption
RMIA will only perform frozen embryo transfers using donated embryos that originated from the RMIA lab, and are stored through Reprotech LTD. Patients interested should call for further details.

Please call RMIA at (651) 222-6050 with any questions or further information regarding these services.